Haemonetics Corporation

Q2 2022 13F Holders

Symbol
HAE
CUSIP
405024100
Type
Equity
Class
COM
Num filings
252
Total reported value, excl. options
$3.39 B
Manager Report Date Value ($000) Shares Option Type